King Pharmaceuticals KG Commercial Auto Liability — Year 6
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's commercial auto liability — year 6.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's commercial auto liability — year 6?
- King Pharmaceuticals (KG) reported commercial auto liability — year 6 of 8.6% in Q4 2025.
- What does commercial auto liability — year 6 mean?
- This metric measures the revenue generated from commercial auto liability insurance offerings during the sixth year of operations. It serves as a key indicator of the company's ability to maintain or expand its footprint in the commercial transportation insurance market. Investors use this to gauge the stability and competitive positioning of the specific insurance segment.